OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics and current standard of care among veterans with major depressive disorder in the United States: A real-world data analysis
Xiaohui Zhao, Swapna Karkare, Abigail I. Nash, et al.
Journal of Affective Disorders (2022) Vol. 307, pp. 184-190
Open Access | Times Cited: 12

Showing 12 citing articles:

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape
Manish K. Jha, Sanjay J. Mathew
American Journal of Psychiatry (2023) Vol. 180, Iss. 3, pp. 190-199
Closed Access | Times Cited: 58

Synthesis, anticancer, α-glucosidase inhibition, molecular docking and dynamics studies of hydrazone-Schiff bases bearing polyhydroquinoline scaffold: In vitro and in silico approaches
Zainab Zainab, Faizullah Khan, Aftab Alam, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139699-139699
Closed Access | Times Cited: 5

Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression – A first-in-kind open-label pilot study
Sara Ellis, Catherine Bostian, Wendy Feng, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 5

Longitudinal Influence of Prescribed Antidepressants on Fecal and Oral Microbiomes Among Veterans With Major Depressive Disorder
Andrew J. Hoisington, Kelly A. Stearns‐Yoder, Christopher E. Stamper, et al.
Journal of Neuropsychiatry (2024) Vol. 36, Iss. 2, pp. 151-159
Closed Access | Times Cited: 3

Pharmacotherapy for Treatment-Resistant Depression
Collin Vas, Ayush Jain, Mili Trivedi, et al.
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 261-275
Open Access | Times Cited: 7

Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naïve patients with major depressive disorder: A large-scale cross-sectional study
Jieqiong Hu, Yunxin Ji, Xiaoe Lang, et al.
Journal of Psychiatric Research (2023) Vol. 163, pp. 55-62
Closed Access | Times Cited: 5

The Impact of Antidepressant Discontinuation Prior to Treatment with Psilocybin for Treatment-Resistant Depression
Lindsey Marwood, Megan Croal, Sunil Mistry, et al.
Journal of Psychiatric Research (2024) Vol. 180, pp. 198-203
Closed Access | Times Cited: 1

Antidepressant use pattern and disparities among cancer patients in the United States
Jingrui Zou, Yong‐Guan Zhu
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 7

Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure
Shingo Miyata, Yugo Ishino, Shoko Shimizu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 5

Two possible mechanisms of ganciclovir for treatment of major depressive disorder
Kazuhiro Itoh, Hiroshi Tsutani, Yasuhiko Mitsuke, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access

Page 1

Scroll to top